Shire Receives FDA “Approvable” Letter On Adult Adderall Product
This article was originally published in The Pink Sheet Daily
Executive Summary
With an adult filing for Adderall replacement Vyvanse set for mid year, the company is weighing its options, Shire told “The Pink Sheet” DAILY.